Up Close and Personal with 2018 Award Winners
Hello Michels Fellowship family! I hope you and your loved ones are safe during the pandemic. I am grateful for the support of my partners in Los Angeles, where my practice has grown exponentially. I have the privilege of taking care of patients of all ages at The Retina Partners, including preterm infants.
My clinical, surgical, and research interests have remained diverse since my fellowship at Associated Retinal Consultants / Beaumont, and include macular degeneration, diabetic retinopathy, macular holes (especially the giant ones!), complex retinal detachments, proliferative vitreoretinopathy, trauma, retinopathy of prematurity, familial exudative vitreoretinopathy, persistent fetal vasculature, and choroidal melanoma.
Philip Storey joined Austin Retina, one of the premier retina groups in the country. Philip completed his retina fellow at Wills Eye Hospital and served as Chief Resident at the University of Southern California Roski Eye Institute. He completed medical training at Johns Hopkins University School of Medicine and received a Masters of Public Health from the University of Sydney.
Philip is passionate about vitreoretinal care and clinical research. His current research projects focus on the efficacy and safety of intravitreal injections of anti-vascular endothelial growth factor agents. Philip has authored or co-authored over 50 publications and book chapters.
Outside of the hospital, Philip enjoys marathons, ironman triathlons, and chasing his two golden retrievers, Georgie and Commando.
I am very honored to be a part of the Michels Foundation Fellowship family! Following my fellowship at Associated Retinal Consultants of William Beaumont Hospital – a truly invaluable experience - I joined the faculty of Stanford University Department of Ophthalmology practicing adult and pediatric vitreoretinal surgery.
In addition to clinical research, my basic science interests are currently focused on creating patient-specific vitreoretinal therapeutics using patient-derived induced pluripotent stem cells (iPSCs), optogenetics, and high-throughput drug discovery screening tools.
In my spare time I enjoy spending time with my family and friends, running and hiking outdoors, traveling, and seeing live music.
I am extremely appreciative and humbled to be part of the Michels Fellowship family. After completing my vitreoretinal fellowship training at the University of Michigan, Kellogg Eye Center, I joined the faculty at the University of Michigan as an Assistant Professor and clinician-scientist.
My independent research laboratory tackles the root cause of vision loss in numerous retinal diseases, photoreceptor cell death. We study the interface of photoreceptor metabolism and survival to develop novel therapeutic paradigms for photoreceptor neuroprotection in order to prevent vision loss in the many people afflicted with retinal disorders. Additionally, I enjoy mentoring the residents and fellows, participating in clinical trials and clinical research projects. I am very fortunate to be surrounded by an amazing team of supportive clinicians and scientists.
Outside of work, I enjoy spending time with my wife and son and keeping a keen eye on Chicago sports.
After graduating from fellowship at Duke, I feel honored to be joining Retina Northwest in Portland, Oregon. I am excited to be joining a group dedicated to excellence in patient care and clinical trials research.
I look forward to being part of the vitreoretinal surgery community and am eager to tackle the challenges of diagnosing and treating medical and surgical retinal diseases. My primary interests include working on patient advocacy, promoting patient education and empowerment to improve clinical outcomes, and implementing projects to optimize healthcare in the community.
Outside of medicine, I enjoy spending time with family, friends, and two loveable dogs hiking, exploring, and enjoying the outdoors.
Have you recently moved? Did you start or join a new practice or change academic institutions? If you would like your information to appear on this News page, please email karen.baranick